2 Biotech Cos. Raise $111M Combined In Low-Priced IPOs
Two venture-backed biotechnology firms developing cancer therapies went public Thursday after raising a combined $111 million in initial public offerings that priced at the bottom of or below their projected ranges...To view the full article, register now.
Already a subscriber? Click here to view full article